Humana Inc (HUM) 177.15 $HUM Will Election 2016 Mean New

New Post Public Reply Private Reply Replies (0) Message Board

Oct 22, 2015 at 12:01 AM

Humana Inc (HUM) 177.15 $HUM

Will Election 2016 Mean New Challenges for Health Insurers?
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 10:50AM CDT
Will Election 2016 Mean New Challenges for Health Insurers?
CI: 136.61 (-5.60), ANTM: 142.79 (-5.45), UNH: 118.11 (-2.31), AET: 108.28 (-3.54), HNT: 63.30 (-0.93), MOH: 66.71 (-2.19), HUM: 177.15 (-8.77)

Clinton questions plans for health insurers to merge
By KEN THOMAS - AP - Wed Oct 21, 10:02AM CDT
WASHINGTON (AP) — Hillary Rodham Clinton warned Wednesday that two major health insurers preparing multibillion dollar acquisitions could tip "the balance of power" too far away from consumers.
CI: 136.61 (-5.60), AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Humana and Guthrie Partner to Offer Value-Based Care in Twin Tiers Region
Business Wire - Wed Oct 21, 9:44AM CDT
Guthrie is teaming up with national health and well-being leader Humana Inc. (NYSE: HUM) on a value-based health care agreement designed to offer Humana's 4,000 Medicare Advantage members in north central Pennsylvania and south central New York an option for a more coordinated, more personalized health care experience.
HUM: 177.15 (-8.77)

Zacks Industry Outlook Highlights: UnitedHealth, Aetna, Cigna, Humana and Anthem
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 8:30AM CDT
Zacks Industry Outlook Highlights: UnitedHealth, Aetna, Cigna, Humana and Anthem
CI: 136.61 (-5.60), ANTM: 142.79 (-5.45), UNH: 118.11 (-2.31), AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Health Insurers Gain Under Obamacare
Zacks Equity Research - Zacks Investment Research - Tue Oct 20, 4:06PM CDT
Health Insurers Gain Under Obamacare
CI: 136.61 (-5.60), ANTM: 142.79 (-5.45), UNH: 118.11 (-2.31), AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Health insurers return to Illinois marketplace
By CARLA K. JOHNSON - AP - Tue Oct 20, 4:01PM CDT
CHICAGO (AP) — Prices are still a mystery, but Illinois consumers shopping for health insurance for 2016 will see familiar companies, newcomers and health plans with narrow networks when the marketplace opens in less than two weeks, according to information released Tuesday by the companies and state regulators.
AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Zacks Industry Outlook Highlights: CIGNA, Anthem, Humana, UnitedHealth Group and Centene
Zacks Equity Research - Zacks Investment Research - Tue Oct 20, 8:30AM CDT
Zacks Industry Outlook Highlights: CIGNA, Anthem, Humana, UnitedHealth Group and Centene
CNC: 58.30 (-1.61), CI: 136.61 (-5.60), ANTM: 142.79 (-5.45), UNH: 118.11 (-2.31), HUM: 177.15 (-8.77)

Oct. 20 Premarket Briefing: 10 Things You Should Know
at The Street - Tue Oct 20, 5:38AM CDT
U.S. stock futures are lower Tuesday ahead of a large number of major corporate earnings reports and housing data.
YHOO: 31.12 (-1.71), MU: 16.43 (-0.66), HOG: 47.03 (-1.22), IBM: 140.92 (+0.28), UTX: 97.97 (+2.35), CMG: 665.67 (-39.96), WDC: 71.44 (-3.42), VZ: 44.86 (-0.38), AET: 108.28 (-3.54), AAPL: 113.76 (-0.01), SNDK: 76.78 (+1.59), HUM: 177.15 (-8.77), UAL: 54.55 (-1.20)

Humana's stockholders approve merger with Aetna
M2 - Tue Oct 20, 4:35AM CDT
Humana Inc (NYSE: HUM) announced on Monday that during a special stockholder meeting held on 19 October 2015, its stockholders voted to approve the adoption of the merger agreement, dated 2 July 2015, providing for the acquisition of Humana by Aetna Inc.
AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Humana, Aetna shareholders approve $37 billion merger
By The Associated Press - AP - Mon Oct 19, 5:20PM CDT
Humana says shareholders at a special meeting overwhelming approved the company's takeover by fellow insurer Aetna.
AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Watch for Humana to Potentially Pullback After Gaining 1.34% Yesterday
Comtex SmarTrend(R) - Mon Oct 19, 4:21PM CDT
Humana (NYSE:HUM) traded in a range yesterday that spanned from a low of $183.90 to a high of $186.79. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $185.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HUM: 177.15 (-8.77)

After Yesterday's Rally of 1.34% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 19, 4:21PM CDT
Humana (NYSE:HUM) traded in a range yesterday that spanned from a low of $183.90 to a high of $186.79. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $185.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HUM: 177.15 (-8.77)

Humana Stockholders Approve Pending Merger with Aetna
Business Wire - Mon Oct 19, 3:45PM CDT
Humana Inc. (NYSE: HUM) announced that during a special stockholder meeting held earlier today, its stockholders voted to approve the adoption of the previously announced merger agreement, dated as of July 2, 2015, providing for the acquisition of Humana by Aetna Inc.
AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Health Insurance Stock Outlook - Oct. 2015
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 1:29PM CDT
Health Insurance Stock Outlook - Oct. 2015
CI: 136.61 (-5.60), CNC: 58.30 (-1.61), ANTM: 142.79 (-5.45), UNH: 118.11 (-2.31), AET: 108.28 (-3.54), HNT: 63.30 (-0.93), HUM: 177.15 (-8.77)

UnitedHealth Group Is a Great Long-Term Investment, Despite Last Week's Earnings Report
at The Street - Mon Oct 19, 12:30PM CDT
UnitedHealth Group (UNH) stock got clobbered in the wake of its earnings release last week, but this stock is a long-term buy. Here's why.
JNJ: 97.63 (+0.04), MRK: 50.59 (+0.20), PFE: 33.46 (-0.54), UNH: 118.11 (-2.31), HUM: 177.15 (-8.77)

Could New ICD-10 Medical Codes Put the Health Industry in Sick Bay?
Bruce Japsen, The Motley Fool - Motley Fool - Mon Oct 19, 9:34AM CDT
From health insurers to large hospital operators, the long-awaited rollout of more than 140,000 new government-mandated ICD-10 codes used for describing diseases and medical procedures in the billing process is being closely monitored for any...
UNH: 118.11 (-2.31), AON: 91.32 (-0.24), HUM: 177.15 (-8.77)

Healthcare M&A Resilient Despite Economic Woes
at The Street - Thu Oct 15, 6:46AM CDT
Despite the financial hardships plaguing some economies, healthcare M&A is still on the rise and experts indicate there is no sign of it slowing.
CI: 136.61 (-5.60), ACT: 298.98 (-2.94), TEVA: 57.92 (+0.03), AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Humana Offers Affordable 2016 Medicare Health Plans, Designed to Help People Get and Stay Healthy
Business Wire - Wed Oct 14, 9:33AM CDT
--Medicare prescription drug plans include Humana Walmart Rx, with the lowest monthly stand-alone national prescription drug plan premium in most states
HUM: 177.15 (-8.77)

Humana Inks ACO Deal with Northwest Physicians Network
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 5:10PM CDT
Humana Inc. (HUM) has entered into a new Accountable Care arrangement.
CNC: 58.30 (-1.61), UNH: 118.11 (-2.31), AET: 108.28 (-3.54), HUM: 177.15 (-8.77)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...